Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Area of Science:

• Neurology
• Immunology

Background:

• Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare, progressive, or relapsing paralytic condition caused by peripheral nerve inflammation.
• The autoimmune hypothesis suggests that removing autoantibodies via plasma exchange may benefit CIDP patients.

Purpose of the Study:

• To evaluate the efficacy of plasma exchange (PLEX) as a treatment for CIDP.

Main Methods:

• Systematic review of randomized controlled trials (RCTs) and quasi-RCTs comparing PLEX to sham treatment or no treatment.
• Data extraction and risk of bias assessment were performed independently by two authors.

Main Results:

• Two small trials (18 and 29 participants) indicated significant short-term improvements in disability and impairment scales with PLEX.
• Electrophysiological measures showed significant motor nerve conduction velocity improvements after PLEX.
• Rapid deterioration occurred in some patients post-treatment, and adverse events were noted.

Conclusions:

• PLEX provides significant short-term benefits for CIDP patients, including improved disability and nerve conduction.
• Potential for rapid deterioration after PLEX and occurrence of adverse events necessitate further research.
• Identifying agents to prolong PLEX's beneficial effects is crucial for long-term CIDP management.